Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q3 2018 · 10-Q
Revenue$78.58K$78.58K−46.8% vs Q3 2017 Net Income-$1.89M-$1.89MN/M vs Q3 2017 EPS Diluted-$0.75-$0.75— vs Q3 2017 Operating Income-$1,401,118N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$431,637— Margins · derivedOperating margin-1783.0%−1333.3 pt vs Q3 2017
Net margin-2400.6%−1653.9 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end